- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02622009
Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients
Human Rhinovirus and Respiratory Syncytial Virus From Bronchoalveolar Lavage and Bronchial Biopsies of Selected Patients With Stable Chronic Obstructive Pulmonary Disease.
Background: The presence of low-grade viral infection in the airways of patients with stable chronic obstructive pulmonary disease (COPD) could potentially have implications in the pathogenesis and progression of the disease, but previous studies have reported very different rates of human rhinovirus (HRV) and respiratory syncytial virus (RSV) genome detection in nasal and sputum samples. However, no study has investigated the presence of these viruses directly in the lungs by bronchoalveolar lavage (BAL) and bronchial biopsies. This study aimed to investigate whether HRV and RSV are present in the lungs of stable COPD patients by performing BAL and bronchial biopsies, and relate their presence with disease severity.
Methods: Consecutive patients with stable COPD and control subjects, who underwent diagnostic (e.g., lung cancer) and/or therapeutic (e.g., hemoptysis) fibreoptic bronchoscopy in a university hospital in Athens, Greece, were enrolled. The collected BAL and bronchial biopsies during bronchoscopy were subsequently processed for HRV and RSV RNA detection with real-time polymerase chain reaction (PCR). More specifically, the nucleocapsid gene and 5΄ non-coding region were searched for RSV and HRV detection, respectively.
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients and control subjects The population of the study consisted of consecutive patients with stable COPD and control subjects, who were referred to the investigators between October 2012 and November 2014 in order to undergo fibreoptic bronchoscopy for diagnostic (e.g., lung cancer) or therapeutic (e.g., hemoptysis) purposes. At study time, the clinical and functional status of COPD patients had been stable for at least 4 weeks, and none had received antibiotic treatment during the last 4 weeks. Exclusion criteria included atopic history, asthma, extensive pleural effusions, bronchiectasis, immunosuppression due to chemotherapy or systemic corticosteroids and all the contraindications of the bronchoscopic procedures. COPD severity was classified using postbronchodilator spirometric values according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Also, the patients were evaluated according to the combined COPD assessment. In this classification the impact of the disease on an individual patient is determined from the combination of the symptomatic assessment (CAT or mMRC scores), the patient's spirometric classification and/or the risk of exacerbations (number of exacerbations and history of hospitalization due to exacerbation in the preceding year).The control group was consisted of non-smokers or current/ex-smokers without COPD. The ex-smoking condition was defined as the cessation of smoking habit at least 1 year previously.
All the participants completed a questionnaire which included demographic characteristics and cigarette smoking status (pack/year). Τhe clinical status was evaluated according to the modified Medical Research Council (mMRC) scale of breathlessness and the Body mass , airflow Obstruction, Dyspnea, Exercise (BODE) index. Pulmonary function testing was performed and arterial blood gases and blood oxygen saturation by pulse oximetry in the sitting position were measured. Patients were asked about the number and the characteristics of the preceding exacerbations, the number and duration of preceding hospitalizations for respiratory disorders, their past medical history (asthma, allergy, sinusitis or nasal polyps), the presence of comorbidities (heart disease, malignancies, e.t.c.), and all the medication they used.
Both the COPD patients and control subjects were appropriately prepared (local anesthesia and intravenous sedation) in order to undergo transnasal fibreoptic bronchoscopy. After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina.
All the samples were aliquoted, frozen and stored within 1 hour after sampling. HRV and RSV detection RNA samples were extracted from BAL and lung biopsies using the Maxwell 16 viral total nucleic acid (Promega). A Nucleocapsid (N) gene partial sequence, as well as a 5΄ non-coding region (5΄NCR) partial sequence were amplified for RSV and HRV, respectively.
Real-time PCR studies were performed. The primers/probes mix, that were used, have broad homology with a large range of HRV serotypes. Also, the primers/probes for RSV are able to distinguish RSV subtypes A and B whilst excluding the closely related human Metapneumoviruses. The primer and probe mix provided exploited the so-called TaqMan principle. A fluorogenic probe was included in the same reaction mixture which consisted of a DNA probe labeled with a 5'-dye and a 3'-quencher. Besides this, the probe was cleaved and the reporter dye and quencher were separated. The resulting increase in fluorescence could be detected on a range of real-time PCR platforms. Each time the kits were used, a positive and a negative control reaction were included in the run.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- stable COPD,indication for bronchoscopic procedure
Exclusion Criteria:
- atopic history, asthma, extensive pleural effusions, bronchiectasis, immunosuppression due to chemotherapy or systemic corticosteroids and all the contraindications of the bronchoscopic procedures
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
COPD I
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE I
|
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
|
COPD II
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE II
|
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
|
COPD III
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE III
|
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
|
NONSMOKERS
BRONCHOSCOPIC PROCEDURE IN NONSMOKERS
|
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
|
CURRENT OR EXSMOKERS
BRONCHOSCOPIC PROCEDURE IN CURRENT OR EXSMOKERS
|
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HRV AND RSV PRESENCE
Time Frame: 7 days
|
A Nucleocapsid (N) gene partial sequence, as well as a 5΄ non-coding region (5΄NCR) partial sequence were amplified for RSV and HRV, respectively.
|
7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: GEORGIOS ARSENIS, PROFESSOR, University of Athens
Publications and helpful links
General Publications
- Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43. doi: 10.1164/rccm.200510-1681OC. Epub 2005 Dec 30.
- Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23. doi: 10.1164/ajrccm.164.9.2105011.
- Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 10451
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HRV and RSV Presence in the Lungs of Stable COPD Patients.
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
University of BolognaCompletedThe Presence of Horizontal and Vertical Alveolar Defects in Both Jaws, Inadequate for the Placement of at Least Two Fixtures, Even ≤6 mm Long Ones
-
The First Affiliated Hospital of Anhui Medical...CompletedLong-term Heart-specific Mortality in the Presence of Competing Risks Among Patients With Gastric Adenocarcinoma Undergoing Resection and Chemotherapy
-
IVI MadridCompletedAge of the Patients and the Body Mass Index in Both Groups
-
NovartisCompletedScreening for the Presence of HIV-1, RNA and HBV DNA in Blood DonationsTaiwan
-
Chun PanUnknownEvaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.China
-
University of ChicagoCompletedTo Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary AngiographyUnited States
-
Hadassah Medical OrganizationCompletedTo Evaluate Effectiveness of the Gait Trainer in Increasing the Functionality and Spatiotemporal Parameters of Gait of 4 Patients.Israel
-
Assistance Publique - Hôpitaux de ParisUniversity of Paris 5 - Rene DescartesCompletedProfessionals and Patients in the Department of Physical Medicine and RehabilitationFrance
-
Zhongshan Bo Ai HospitalCompletedThe Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group; | At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether; | 534... and other conditionsChina
Clinical Trials on BRONCHOSCOPIC PROCEDURE
-
Ambu A/STerminatedBronchoscopy | AtelectasisUnited States
-
Pulmonx CorporationActive, not recruiting
-
Broncus TechnologiesHeidelberg UniversityUnknown
-
Nordsjaellands HospitalCompleted
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Lung CancerUnited States
-
Medtronic - MITGCompletedCancer, Lung | Cancer, Metastatic to LungHong Kong, United Kingdom
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownDiagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL (SHSYXY-BAL)Lung Infection | Bronchoalveolar Lavage Fluid
-
phenoMapper, LLCNIH/NCI - Grant award number: R01CA218357Recruiting
-
University Medical Center GroningenRecruitingPulmonary Nodules, SolitaryNetherlands
-
University Medical Center GroningenCompletedEmphysema | COPDNetherlands